PATENT CLAIM ANALYSIS

Application Number: 15926204
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["544", "350000"]

Abstract:
There is provided a series of coelenterazine (CTZ) derivatives as a substrate with high luminescence intensity, which is optimal for maximum luminescence wavelengths at both 400 nm (blue-shifted RLuc luminescence system) and 500 nm (ALuc luminescence system) for bioassays which is more sensitive than known techniques. The novel CTZ derivatives are compounds in which a specific position(s) of the CTZ is/are substituted with a specific substituent(s) as shown, for example, by the Formula [I], and has a higher luminescence intensity than known CTZ derivatives in blue-shifted RLuc luminescence system or ALuc luminescence system.

Claim (Index 5):
The compound according to  claim 3 , wherein R 1  represents \u2014OH, and R 2  represents \u2014O\u2014(CH 2 ) 2 \u2014N 3 .

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 1.82258
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15030281', '14283943', '14826384', '13973477', '13146784']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7522862057787181
- 35 USC 102 Novelty (BERT): 0.5087586458737874
- Combined Prediction Score: 0.7279334497882249
- Mean Citation Score: 255.70168200000003
- Max Citation Score: 264.2719
- Similarity Product: 191.7215732792497

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test